Investor Announcements - 2014
|
| ||
The open offer to qualifying participants has been over-subscribed. | ||
| ||
EKF Diagnostics announces that it has entered into a conditional agreement to acquire Selah Genomics, Inc. and DiaSpect Medical AB.a Swedish based manufacturer of point-of-care haemoglobin analysers. | ||
| ||
EKF Diagnostics announces its audited final results for the year ended 31 December 2013, a year of strong organic growth and improved earnings. | ||
| ||||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.